Literature DB >> 3530901

Osteocalcin: the vitamin K-dependent Ca2+-binding protein of bone matrix.

P V Hauschka.   

Abstract

Osteocalcin is an abundant Ca2+-binding protein indigenous to the organic matrix of bone, dentin, and possibly other mineralized tissues. This protein contains 47-50 amino acid residues (molecular weight 5,200-5,900) depending on the species. Osteocalcin is distinguished by its content of three gamma-carboxyglutamic (Gla) residues. The vitamin-K-dependent biosynthesis of osteocalcin occurs in bone, and the protein is not homologous to the Gla-containing regions of known vitamin-K-dependent blood coagulation proteins. The two major structural features of osteocalcin which appear to control its function include: the 'Gla helix', a compact Ca2+-dependent alpha-helical conformation, in which the three Gla residues are aligned to facilitate adsorption to hydroxyapatite, and the 'COOH-terminal beta-sheet' which exhibits chemoattractant activity toward mononuclear leukocytes, specifically monocytes, the putative precursors of osteoclasts. While the biological function of osteocalcin is unknown, it appears to be a highly specific osteoblastic marker produced during bone formation, and is rapidly becoming a clinically important diagnostic parameter of bone pathology. This article reviews recent advances in the understanding of osteocalcin.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3530901     DOI: 10.1159/000215298

Source DB:  PubMed          Journal:  Haemostasis        ISSN: 0301-0147


  22 in total

Review 1.  How pleiotropic genetics of the musculoskeletal system can inform genomics and phenomics of aging.

Authors:  David Karasik
Journal:  Age (Dordr)       Date:  2010-07-02

Review 2.  A four-season molecule: osteocalcin. Updates in its physiological roles.

Authors:  Giovanni Lombardi; Silvia Perego; Livio Luzi; Giuseppe Banfi
Journal:  Endocrine       Date:  2014-08-27       Impact factor: 3.633

3.  Vitamin K2 promotes 1alpha,25(OH)2 vitamin D3-induced mineralization in human periosteal osteoblasts.

Authors:  Y Koshihara; K Hoshi; H Ishibashi; M Shiraki
Journal:  Calcif Tissue Int       Date:  1996-12       Impact factor: 4.333

4.  Oct-1 counteracts autoinhibition of Runx2 DNA binding to form a novel Runx2/Oct-1 complex on the promoter of the mammary gland-specific gene beta-casein.

Authors:  Claire K Inman; Na Li; Paul Shore
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

5.  Injectable Peptide Decorated Functional Nanofibrous Hollow Microspheres to Direct Stem Cell Differentiation and Tissue Regeneration.

Authors:  Zhanpeng Zhang; Melanie J Gupte; Xiaobing Jin; Peter X Ma
Journal:  Adv Funct Mater       Date:  2015-01-21       Impact factor: 18.808

6.  Localization of endogenous osteocalcin in neonatal rat bone and its absence in articular cartilage: effect of warfarin treatment.

Authors:  G Boivin; G Morel; J B Lian; C Anthoine-Terrier; P M Dubois; P J Meunier
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

7.  Meckel's cartilage chondrocytes in organ culture synthesize bone-type proteins accompanying osteocytic phenotype expression.

Authors:  K Ishizeki; M Takigawa; Y Harada; F Suzuki; T Nawa
Journal:  Anat Embryol (Berl)       Date:  1996-01

Review 8.  Proper Calcium Use: Vitamin K2 as a Promoter of Bone and Cardiovascular Health.

Authors:  Katarzyna Maresz
Journal:  Integr Med (Encinitas)       Date:  2015-02

9.  Development of a heterologous radioimmunoassay for canine osteocalcin.

Authors:  S P Wang; K T Demarest; J W Gunnet; D J Baylink; K H Lau
Journal:  Calcif Tissue Int       Date:  1994-08       Impact factor: 4.333

10.  Transforming growth factor β suppresses osteoblast differentiation via the vimentin activating transcription factor 4 (ATF4) axis.

Authors:  Na Lian; Tonghui Lin; Wenguang Liu; Weiguang Wang; Lingzhen Li; Stephanie Sun; Jeffry S Nyman; Xiangli Yang
Journal:  J Biol Chem       Date:  2012-09-04       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.